Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 112.31M
March 31, 2026 117.63M
December 31, 2025 139.34M
September 30, 2025 147.26M
June 30, 2025 183.95M
March 31, 2025 208.46M
December 31, 2024 209.54M
September 30, 2024 228.18M
June 30, 2024 261.65M
March 31, 2024 293.99M
December 31, 2023 328.83M
September 30, 2023 338.49M
Date Value
June 30, 2023 259.23M
March 31, 2023 228.54M
December 31, 2022 247.66M
September 30, 2022 293.37M
June 30, 2022 339.92M
March 31, 2022 353.73M
December 31, 2021 375.83M
September 30, 2021 435.31M
June 30, 2021 129.52M
March 31, 2021 145.92M
December 31, 2020 15.95M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Intellia Therapeutics, Inc. 437.76M
Vir Biotechnology, Inc. 534.66M
Arrowhead Pharmaceuticals, Inc. 1.602B
Oncolytics Biotech, Inc. 4.115M
Sangamo Therapeutics, Inc. 27.59M